Sekkarie, Ahlia
Welsh, Jean A.
Northstone, Kate
Stein, Aryeh D.
Ramakrishnan, Usha
Vos, Miriam B.
Article History
Received: 22 February 2021
Accepted: 22 April 2021
First Online: 8 July 2021
Declarations
:
: Ethical approval for the study was obtained from the ALSPAC Ethics and Law Committee and the data from the 24 Year Clinic was approved by the National Research Ethics Service Committee South West—Frenchay: 14/SW/1173 ALSPAC Focus at 24 + (24 February 2015, confirmed 20 March 2015). Informed consent for the use of collected data via questionnaires and clinics was obtained from participants following the recommendations of the ALSPAC Ethics and Law Committee at the time.
: Not applicable.
: A.S., J.A.W, K.N., A.D.S, and U.R. declare that they have no competing interests. M.B.V. reports personal fees from Intercept, grants from Immuron, grants and personal fees from Target Pharmasolutions, personal fees from Boehringer Ingelheim, grants and personal fees from Bristol Myers Squibb, personal fees from Prosciento, and personal fees from Novo Nordisk during the conduct of the study.